PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Tranexamic acid reduces heme cytotoxicity via the TLR4/TNF axis and ameliorates functional recovery after spinal cord injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31358003 ↗2019Reported benefit

Tranexamic acid reduces heme cytotoxicity via the TLR4/TNF axis and ameliorates functional recovery after spinal cord injury.

MouseSpinal cord injuryContusionC57BL/6NFemalen = 92 mice in total; n = 6 per group for CD11b/TLR4 ratio and…Intraperitoneal for tranexamic acid; subcutaneous for heparinTranexamic acid 1 mg per g body weight, diluted to 10 mg/ml…Tranexamic acid immediately after spinal cord injury; heparin and saline at 1 a…

Model: Moderate contusion spinal cord injury (70 kdyn) at the 9th thoracic level using an Infinite Horizons Impactor under pentobarbital anaesthesia (75 mg/kg intraperitoneally); separate experiments injected packed or lysed red blood cells or haem solution (125 or 250 microM, 2 microL at 1 microL/min) into naive spinal cord at T9

Tranexamic acid given immediately after contusion spinal cord injury significantly reduced intralesional red blood cell volume, bleeding area, haem content and demyelinated area compared with saline, whereas heparin worsened these measures. Tranexamic acid also reduced TLR4, TNF, MyD88 and NF-kB p6…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.